Feedback / Questions
Rituximab BS (rituximab biosimilar) - Kyowa Hakko Kirin
Result presentation fiscal 2018 first quarter
(Kyowa Hakko Kirin Pharma Press Release)
-
May 9, 2018 -
Launched in Japan in Jan 2018.
Launch Japan
•
Biosimilar
http://ir.kyowa-kirin.com/en/library/earnings/earnings1/main/00/teaserItems1/00/linkList/01/link/presentation_2018_q1_en.pdf
May 9, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious